Board logo

subject: Orchid Chemicals & Pharmaceuticals Ltd (524372) - Financial And Strategic Analysis Review [print this page]


Aarkstore announce a new report "Orchid Chemicals & Pharmaceuticals Ltd (524372) - Financial and Strategic Analysis Review" through its vast collection of market research report.

Orchid Chemicals & Pharmaceuticals Ltd (Orchid) is a publicly held Indian based global integrated pharmaceutical company. The company is principally engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms as well as involved in drug discovery. It has six subsidiaries located in Japan, India, South Africa, South America, the UK and the US. The company operates through two manufacturing facilities located in Chennai and Aurangabad, which produces APIs, as well as three sites for dosage forms at Irungattukottai and Alathur in Chennai.

Orchid Chemicals & Pharmaceuticals Ltd Key Recent Developments

Jan 08, 2010: Orchid Receives Tentative FDA Approval For Memantine Tablets

Dec 16, 2009: Hospira To Acquire Generic Injectable Pharmaceuticals Business From Orchid

Aug 11, 2009: Schering-Plough Signs Agreement With Orchid

This comprehensive SWOT profile of Orchid Chemicals & Pharmaceuticals Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Orchid Chemicals & Pharmaceuticals Ltd, including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit:

http://www.aarkstore.com/reports/Orchid-Chemicals-Pharmaceuticals-Ltd-524372-Financial-and-Strategic-Analysis-Review-47683.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)